Genmab AS

Genmab AS Book Value per Share

The Book Value per Share of Genmab AS (GMAB) as of Nov 22, 2026 is 9.50 USD. In the previous year, Book Value per Share was 59.77 USD — a change of -84.10% (lower).

Book Value per Share

9.50USD

YoY

-84.10%

Last updated:

Book Value per Share of Genmab AS is 2025 9.50 USD. Book Value per Share of Genmab AS was 2024 59.77 USD. It decreases by -84.10% lower compared to the previous year.

The Genmab AS Book Value per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Book Value per Share
Date
Book Value per Share
Jan 1, 2018
13.05 USD
Jan 1, 2019
22.88 USD
Jan 1, 2020
31.15 USD
Jan 1, 2021
36.15 USD
Jan 1, 2022
44.44 USD
Jan 1, 2023
51.49 USD
Jan 1, 2024
59.77 USD
Jan 1, 2025
9.50 USD
The Genmab AS Book Value per Share history
YEARBook Value per ShareYoY
9.50USD-84.10%
59.77USD+16.09%
51.49USD+15.86%
44.44USD+22.91%
36.15USD+16.08%
31.15USD+36.11%
22.88USD+75.29%
13.05USD+27.78%
10.22USD+29.95%
7.86USD+38.43%
5.68USD+71.51%
3.31USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Genmab AS Stock analysis

What does Genmab AS do? Genmab AS is a biotechnology company based in Copenhagen, Denmark, operating in the Health Care sector. It develops and markets antibody-based therapies for cancer and other diseases, including EPKINLY, TEPKINLY, and Tivdak for various lymphomas and cervical cancer. The company also advances several product candidates in clinical development, such as Epcoritamab for lymphomas and GEN1059 for solid tumors, alongside established treatments like DARZALEX and TECVAYLI for multiple myeloma and other conditions. Genmab AS is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Genmab AS stock

Book Value per Share of Genmab AS is 9.50 USD in 2025.

Book Value per Share of Genmab AS changed from 59.77 USD to 9.50 USD, representing a -84.10% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Book Value per Share Genmab AS since 2006 – with annual values, charts, and detailed analysis.

Book value per share represents the net asset value of the company per outstanding share. Comparing it to the stock price helps assess whether a stock is undervalued.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Genmab AS

All Key Metrics — Genmab AS